Cresud S.A.C.I.F. y A. (CRESY) vs NN, Inc. (NNBR)

Cresud S.A.C.I.F. y A. and NN, Inc. are both Conglomerates companies. Cresud S.A.C.I.F. y A. is the larger, with a market value of $640.5M against $250.3M — 2.6× the size. NN, Inc. has negative trailing earnings, so its P/E is not meaningful; Cresud S.A.C.I.F. y A. trades at 4.9×. NN, Inc. grew revenue faster over the last twelve months: 13.9% against 5.62%. Cresud S.A.C.I.F. y A. has the higher net margin (12.9% vs −9.49%) and the higher return on invested capital (6.97% vs −3.12%). Across the 19 metrics below, Cresud S.A.C.I.F. y A. leads on 15 and NN, Inc. on 4.

Valuation

Metric CRESY NNBR Conglomerates median
P/E 4.88 n/m 10.31
P/S 0.62 0.43 0.61
P/B 0.27 2.01 1.14
Price to free cash flow 14.01 n/m 14.01
EV/EBITDA 3.37 15.73 10.13
EV/Sales 1.10 0.76 1.29
Earnings yield 20.51% (29.54%) 2.65%
Free cash flow yield 7.14% (0.56%) 0.00%

Profitability

Metric CRESY NNBR Conglomerates median
Gross margin 39.01% 14.33% 30.27%
Operating margin 30.86% (3.06%) 3.46%
Net margin 12.85% (9.49%) 1.95%
Free cash flow margin 4.41% (0.24%) 0.00%
Return on equity 5.61% (59.79%) 0.94%
Return on assets 2.44% (10.16%) 0.06%
Return on invested capital 6.97% (3.12%) 0.73%

Growth

Metric CRESY NNBR Conglomerates median
Revenue growth (TTM) 5.62% 13.92% 6.98%
EPS growth (last fiscal year) 35.46% 3.60% 12.05%
Revenue growth, 5-year CAGR 13.85% (0.25%) 6.85%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CRESY NNBR Conglomerates median
Debt to equity 0.46 1.21 0.43
Current ratio 1.47 1.75 1.47
Net debt to EBITDA 1.47 8.01 1.17

Dividend

Metric CRESY NNBR Conglomerates median
Dividend yield 6.77% — 2.77%
Payout ratio 0.34 — 0.35

Size

Metric CRESY NNBR Conglomerates median
Market cap 640.50m 250.29m 422.37m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack